R&D, strategic alliances and shareholder value in biotech industry.

The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" v...

Full description

Saved in:

Bibliographic Details
Main Author:	Teng, Poi Leng.
Other Authors:	Tan, Patricia Mui Siang
Format:	Theses and Dissertations
Published:	2008
Subjects:	DRNTU::Business::Industries and labor
Online Access:	http://hdl.handle.net/10356/7721
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Nanyang Technological University

id	sg-ntu-dr.10356-7721
record_format	dspace
spelling	sg-ntu-dr.10356-77212024-01-12T10:13:30Z R&D, strategic alliances and shareholder value in biotech industry. Teng, Poi Leng. Tan, Patricia Mui Siang Nanyang Business School DRNTU::Business::Industries and labor The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" value driver is able to add value and create shareholders' wealth by exploring the various roles of strategic alliances. This study hopes to provide a better understanding of strategic alliances and thus, help shape proposals for improved information disclosure on organizational capital. Master of Accountancy 2008-09-18T07:50:12Z 2008-09-18T07:50:12Z 2004 2004 Thesis http://hdl.handle.net/10356/7721 Nanyang Technological University application/pdf
institution	Nanyang Technological University
building	NTU Library
continent	Asia
country	Singapore Singapore
content_provider	NTU Library
collection	DR-NTU
topic	DRNTU::Business::Industries and labor
spellingShingle	DRNTU::Business::Industries and labor Teng, Poi Leng. R&D, strategic alliances and shareholder value in biotech industry.
description	The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" value driver is able to add value and create shareholders' wealth by exploring the various roles of strategic alliances. This study hopes to provide a better understanding of strategic alliances and thus, help shape proposals for improved information disclosure on organizational capital.
author2	Tan, Patricia Mui Siang
author_facet	Tan, Patricia Mui Siang Teng, Poi Leng.
format	Theses and Dissertations
author	Teng, Poi Leng.
author_sort	Teng, Poi Leng.
title	R&D, strategic alliances and shareholder value in biotech industry.
title_short	R&D, strategic alliances and shareholder value in biotech industry.
title_full	R&D, strategic alliances and shareholder value in biotech industry.
title_fullStr	R&D, strategic alliances and shareholder value in biotech industry.
title_full_unstemmed	R&D, strategic alliances and shareholder value in biotech industry.
title_sort	r&d, strategic alliances and shareholder value in biotech industry.
publishDate	2008
url	http://hdl.handle.net/10356/7721
_version_	1789482972401893376

R&D, strategic alliances and shareholder value in biotech industry.

Similar Items